BioSpace News Archive

Novo Nordisk filed a lawsuit in a Delaware district court against generic drugmaker Mylan. The suit is an attempt to block Mylan from marketing a generic version of Novo Nordisk’s diabetes drug Victoza.

Here are some reasons why mentoring is important for biotech careers.

Emery Pharma and CP Lab Safety will be attending the American Chemical Society’s National Meeting & Expo in San Diego, California on August 25 – 27, 2019.

Retrophin, Inc. announced that the Phase 3 FORT Study evaluating the safety and efficacy of fosmetpantotenate compared to placebo in patients with pantothenate kinase-associated neurodegeneration did not meet its primary endpoint and did not demonstrate a difference between treatment groups.

Study will evaluate outcomes from integrating oral health care with community health center services

CEOs Share Breakthroughs, Insights and Opportunities at “Think Asia, Think Hong Kong” Symposium

Shares of Retrophin have plunged more than 24% in premarket trading after the San Diego-based company announced its Phase III treatment for pantothenate kinase-associated neurodegeneration did not stack up against placebo.

Predictive Laboratories, a biotech company focused on genetic testing to understand human infertility and women’s health recently formed in 2017, is making an effort to speed up its research with a recently announced collaboration with Thermo Fisher Scientific, which is a major player in female infertility research.

Today, Mission Bio announced the addition of Copy Number Analysis, which extends the platform’s Copy Number Variation capabilities without any change to the current workflow.

Diagnostica Stago, introduces the STA Workcell Max, a transformative specimen processing platform designed to meet the rigorous requirements of efficient hemostasis testing.